Consumer Protection
Maine is first to protect consumers from home equity investment loans
Law provides Mainers with the most comprehensive protections in the country
James R. Hood
James R. Hood, an editor and consumer-affairs journalist with more than five decades of experience, has held senior editorial leadership roles at The Associated Press, United Press International, Zapnews and ConsumerAffairs.
Health
Trump pushes psychedelics into the policy mainstream with new research order
Support from veterans and some health officials meets skepticism from critics warning of safety risks and hype
Health
Drug poisoning risk rises with use of gabapentin and similar medications
Elevated risk can persist for months, researchers find
Spirit Airlines faces collapse as fuel prices spike
Flights are still operating normally for now, but the next few weeks could determine whether Spirit survives
Consumer Protection
'Click to Cancel' rule coming to NYC but still blocked nationwide by a court ruling
Nothing annoys consumers more than being trapped in self-renewing subscriptions that are nearly impossible to break
Health
Anti-aging claims may be anti-factual, researchers warn
New research suggests many anti-aging claims may be overstated — and could reshape how drugs and therapies are developed
Consumer Protection
CFPB can't go home again; Trump canceled its lease
The agency returned billions to consumers but has been largely shut down by the Trump White House
Consumer Protection
Immigration crackdown fuels wave of scams targeting vulnerable migrants
Victims pay thousands for fake legal help, bogus “protection” services
Seniors
Cannabis use surges among older Americans — but brain health risks remain unclear
Studies link heavy use to memory and cognitive impairment, especially with early exposure
Consumer Protection
FTC cracks down on $8.8 million student loan relief scam that targeted struggling borrowers
Case highlights surge in “debt relief” fraud as millions of borrowers navigate repayment confusion
Consumer Protection
Jury finds Live Nation/Ticketmaster liable for monopolizing concert ticket market
States say fans were overcharged and rivals were shut out of venues
Health
FDA weighs loosening restrictions on experimental peptides amid safety concerns
Push backed by Robert F. Kennedy Jr., but scientists warn of limited safety data